Page 1 | Search Results | Blood | American Society of Hematology

1-11 of 11

Sort by

Sort Order Select

Journal Articles

RAD51 Degradation Triggered By MALAT1 Silencing Confers Synthetic Lethality to PARPi in AML

Fang Xie, Jiong Hu, Jinsong Yan

Blood (2024) 144 (Supplement 1): 5745.

https://doi.org/10.1182/blood-2024-209982

Published: 2024

Journal Articles

The histone methyltransferase Ezh2 is a crucial epigenetic regulator of allogeneic T-cell responses mediating graft-versus-host disease

Shan He, Fang Xie, Yongnian Liu, Qing Tong, Kazuhiro Mochizuki, Philip E. Lapinski, Ram-Shankar Mani, Pavan Reddy, Izumi Mochizuki, Arul M. Chinnaiyan, Shin Mineishi, Philip D. King, Yi Zhang

Blood (2013) 122 (25): 4119–4128.

https://doi.org/10.1182/blood-2013-05-505180

Published: 2013

Includes: Supplemental data

Journal Articles

The Epigenetic Regulator Ezh2 Is An Effective Target For Controlling Th1 Cell-Mediated Acquired Aplastic Anemia In Mice

Qing Tong, MD, Shan He, PhD, Fang Xie, Amanda Wong, Kazuhiro Mochizuki, MD, PhD, Yongnian Liu, MS, Izumi Mochizuki, MD, Shin Mineishi, MD, Yi Zhang, MD, PhD

Blood (2013) 122 (21): 2467.

https://doi.org/10.1182/blood.V122.21.2467.2467

Published: 2013

Journal Articles

The Histone Methyltransferase Ezh2 Is a Crucial Epigenetic Regulator Of Allogeneic T Cell Responses and Graft-Versus-Host Disease In Mice

Shan He, PhD, Fang Xie, Yongnian Liu, MS, Qing Tong, MS, Kazuhiro Mochizuki, MD, PhD, Philip E Lapinski, PhD, Pavan Reddy, MD, Izumi Mochizuki, MD, Arul M. Chinnaiyan, MD, PhD, Shin Mineishi, MD, Philip D King, PhD, Yi Zhang, MD, PhD

Blood (2013) 122 (21): 137.

https://doi.org/10.1182/blood.V122.21.137.137

Published: 2013

Journal Articles

Identification of Previously Uncharacterized Delta 4-Positive Inflammatory Plasmacytoid Dendritic Cells That Play Important Roles in Eliciting Graft-Versus-Host Disease in Mice

Kazuhiro Mochizuki, MD, PhD, Fang Xie, MD, Shan He, PhD, Qing Tong, MS, Yongnian Liu, MS, Yajun Guo, MD, PhD, Koji Kato, MD, PhD, Hideo Yagita, PhD, Shin Mineishi, Yi Zhang, MD, PhD

Blood (2012) 120 (21): 337.

https://doi.org/10.1182/blood.V120.21.337.337

Published: 2012

Journal Articles

Iron Overload Impairs Hematopoiesis by Damaging MSCs Through ROS Signaling Pathway.

Wenyi Lu, MD, Mingfeng Zhao, MD&PhD, Xiao Chai, MD, Juanxia Meng, MD, Fang Xie, MD, Juan Mu, MD, Haibo Zhu, MD, Xinnv Xu, PhD, Xia Xiao, MD, Qi Deng, MD, Li Ma, PhD

Blood (2012) 120 (21): 2097.

https://doi.org/10.1182/blood.V120.21.2097.2097

Published: 2012

Journal Articles

Histone Methyltransferase Ezh2 Controls T-Cell Immunity by Regulating Bioenergetic Metabolism

Shan He, PhD, Fang Xie, MD, Qing Tong, MS, Kazuhiro Mochizuki, MD, PhD, Yongnian Liu, MS, Philip E Lapinski, PhD, Shin Mineishi, Ram Shankar Mani, MD, Victor E Marquez, Arul M. Chinnaiyan, MD, PhD, Philip D King, PhD, Yi Zhang, MD, PhD

Blood (2012) 120 (21): 953.

https://doi.org/10.1182/blood.V120.21.953.953

Published: 2012

Journal Articles

Inhibition of histone methylation arrests ongoing graft-versus-host disease in mice by selectively inducing apoptosis of alloreactive effector T cells

Shan He, Jina Wang, Koji Kato, Fang Xie, Sooryanarayana Varambally, Shin Mineishi, Rork Kuick, Kazuhiro Mochizuki, Yongnian Liu, Evelyn Nieves, Ram-Shankar Mani, Arul M. Chinnaiyan, Victor E. Marquez, Yi Zhang

Blood (2012) 119 (5): 1274–1282.

https://doi.org/10.1182/blood-2011-06-364422

Published: 2012

Includes: Supplemental data

Journal Articles

Inhibition of Histone Methylation Arrests Ongoing Graft-Versus-Host Diseases in Mice by Selectively Inducing Apoptosis of Alloreactive Effector T Cells

Shan He, PhD, Jina Wang, MD, Koji Kato, MD, PhD, Fang Xie, MD, Sooryanarayana Varambally, MD, Shin Mineishi, MD, Rork Kuick, MS, Kazuhiro Mochizuki, MD, Yongnian Liu, MS, Evelyn Nieves, PhD, Ram Mani, MD, Arul M. Chinnaiyan, MD, PhD, Victor E. Marquez, PhD, Yi Zhang, MD, PhD

Blood (2011) 118 (21): 820.

https://doi.org/10.1182/blood.V118.21.820.820

Published: 2011

Journal Articles

Increased Intracellular Concentration of Reactive Oxygen Species Mediated the Deficient Hematopoiesis of Iron Overload Bone Marrow

Mingfeng Zhao, MD&PhD, Fang Xie, MD, Yuming Li, MD, Juan Mu, MD, Xia Xiao, MD, Haibo Zhu, MD, Xinnv Xu, PhD, Qi Deng, MD, Pengjiang Liu, MD, Li Geng, MD, Zonghong Shao, MD

Blood (2010) 116 (21): 4247.

https://doi.org/10.1182/blood.V116.21.4247.4247

Published: 2010

Journal Articles

Pegfilgrastim (Neulasta®) and Filgrastim (Neupogen®) Use in Patients Receiving Chemotherapy in Oncology Practices: Interim Results of the Assessment of Current CSF Evaluation for Proper Therapy (ACCEPT) Study.

Luis Alberto Meza, MD, Veena Charu, MD, Roger Dansey, MD, Fang Xie, PhD, Bradley Stolshek, PharmD

Blood (2004) 104 (11): 5309.

https://doi.org/10.1182/blood.V104.11.5309.5309

Published: 2004

NARROW

RAD51 Degradation Triggered By MALAT1 Silencing Confers Synthetic Lethality to PARPi in AML

The histone methyltransferase Ezh2 is a crucial epigenetic regulator of allogeneic T-cell responses mediating graft-versus-host disease

The Epigenetic Regulator Ezh2 Is An Effective Target For Controlling Th1 Cell-Mediated Acquired Aplastic Anemia In Mice

The Histone Methyltransferase Ezh2 Is a Crucial Epigenetic Regulator Of Allogeneic T Cell Responses and Graft-Versus-Host Disease In Mice

Identification of Previously Uncharacterized Delta 4-Positive Inflammatory Plasmacytoid Dendritic Cells That Play Important Roles in Eliciting Graft-Versus-Host Disease in Mice

Iron Overload Impairs Hematopoiesis by Damaging MSCs Through ROS Signaling Pathway.

Histone Methyltransferase Ezh2 Controls T-Cell Immunity by Regulating Bioenergetic Metabolism

Inhibition of histone methylation arrests ongoing graft-versus-host disease in mice by selectively inducing apoptosis of alloreactive effector T cells

Inhibition of Histone Methylation Arrests Ongoing Graft-Versus-Host Diseases in Mice by Selectively Inducing Apoptosis of Alloreactive Effector T Cells

Increased Intracellular Concentration of Reactive Oxygen Species Mediated the Deficient Hematopoiesis of Iron Overload Bone Marrow

Pegfilgrastim (Neulasta®) and Filgrastim (Neupogen®) Use in Patients Receiving Chemotherapy in Oncology Practices: Interim Results of the Assessment of Current CSF Evaluation for Proper Therapy (ACCEPT) Study.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only